The FDA has announced nationwide recall of SangCya oral solution (SangStat Medical Corp, Fremont, Calif), a generic version of the antirejection drug cyclosporine (Neoral oral solution). Cyclosporine capsules are not affected.
The FDA asked the sponsor to recall the product because of clinical evidence, recently made available to the agency by SangStat Medical Corp, that the generic drug's availability is low relative to Neoral oral solution when administered with apple juice.
Henney JE. Nationwide Recall of SangCya Oral Solution. JAMA. 2000;284(10):1234. doi:10.1001/jama.284.10.1234-JFD00007-4-1
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: